AKT1 and cancer: AKT dysregulation is implicated in a wide range of diseases, including cancer, cardiovascular diseases, insulin resistance, type 2 diabetes, inflammation, autoimmune disorders, and neurological disorders (Jones et al., 1991; Manning and Toker, 2017).